Related Experiment Video
Updated: Aug 21, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
The consequences of insulin-like growth factors/receptors dysfunction in lung cancer
Jasminka Pavelic1, Simun Krizanac, Sanja Kapitanovic
1Division of Molecular Medicine, Rudjer Boskovic Institute, Bijenicka 54, P. Box 180, HR-10002 Zagreb, Croatia. jpavelic@irb.hr
Abstract:
The aim of this study was to investigate the consequences of insulin-like growth factors (IGF) and IGF receptor dysfunction in lung carcinomas. A correlation between increased expression (at mRNA and protein levels) for IGF-1 and IGF-1R and decreased apoptosis were found in large-cell carcinomas and adenocarcinomas. In 40% of informative adenocarcinomas expressing the highest values of IGF-2 and Ki-67 proteins, M6P/IGF-2R gene had LOH at one allele and a mutation in another allele. All four squamous cell carcinoma samples expressed LOH/mutation in the M6P/IGF-2R gene. The alphaIR3 strongly diminished proliferation and increased apoptosis in cultures established from squamous cell carcinomas overexpressing IGF-2 and IGF-1R. Telomerase activity was assessed in four squamous cell carcinomas. Cell treatment with IGF-1 increased telomerase activity. The opposite was observed when the cells were treated with alphaIR3, which inhibits the activity of IGF-1 receptors. Our findings suggest that disruption of the IGF/IGF receptors axis is involved in lung cancer formation.
Insights
Disruption of insulin-like growth factor (IGF) signaling pathways is linked to lung cancer development. Targeting IGF receptors with alphaIR3 may inhibit tumor growth and increase apoptosis in lung carcinomas.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Insulin-like growth factors (IGFs) and their receptors play crucial roles in cell growth and survival.
- Dysregulation of the IGF signaling pathway is implicated in various cancers, including lung carcinoma.
- Understanding the specific roles of IGFs and their receptors in different lung cancer subtypes is essential.
Purpose of the Study:
- To investigate the role of insulin-like growth factors (IGF) and IGF receptor dysfunction in lung carcinomas.
- To explore the correlation between IGF expression and apoptosis in lung cancer.
- To examine the impact of targeting IGF receptors on lung cancer cell proliferation and apoptosis.
Main Methods:
- Analysis of IGF-1 and IGF-1R mRNA and protein expression in lung carcinoma tissues.
- Detection of loss of heterozygosity (LOH) and mutations in the M6P/IGF-2R gene.
- In vitro studies using alphaIR3 antibody to assess its effects on lung cancer cell proliferation and apoptosis.
- Measurement of telomerase activity in response to IGF-1 and alphaIR3 treatment.
Main Results:
- Increased expression of IGF-1 and IGF-1R correlated with decreased apoptosis in large-cell carcinomas and adenocarcinomas.
- Loss of heterozygosity (LOH) and mutations in the M6P/IGF-2R gene were observed in adenocarcinomas and squamous cell carcinomas.
- The alphaIR3 antibody significantly reduced proliferation and increased apoptosis in squamous cell carcinoma cell cultures.
- IGF-1 treatment enhanced telomerase activity, while alphaIR3 inhibited it in squamous cell carcinomas.
Conclusions:
- Disruption of the IGF/IGF receptors axis is involved in lung cancer formation.
- IGF signaling pathways represent potential therapeutic targets for lung cancer treatment.
- Specific IGFs and their receptors may have distinct roles in different lung carcinoma subtypes.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Abnormal Proliferation